Kofi Ampadu, the partner at a16z who led the firm’s Talent x Opportunity (TxO) fund and program, has left the firm, according to an email he sent to staff that TechCrunch obtained. This comes months ...

Resection followed by adjuvant chemotherapy is the standard treatment for high-risk stage II and stage III colon cancer, but recurrence affects 20–40% of patients. Observational studies suggest that ...